Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7974

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7974). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This is a statistical analysis output of a study comparing the hazard ratio (HR) of two groups, possibly a treatment group (Rosuvastatin) and a control group (Placebo). The hazard ratio is 0.56 with a 95% confidence interval of 0.46-0.69, indicating a significant difference between the two groups (P<0.001). The table also shows the cumulative incidence in percentages for each group over time. The number at risk is provided for each time point in the study for both the Rosuvastatin and Placebo groups.*
FDA Label Image

Figure2 (Image 01)

Figure2 (Image 01)
This document provides data on the number of events for different endpoints comparing the effects of Rosuvastatin 20 mg versus placebo. The Hazard Ratios with 95% confidence intervals are reported for each endpoint, such as the primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. The P values are also included, indicating the statistical significance of the findings. These results suggest that Rosuvastatin at 20 mg may have a beneficial effect in reducing the risk of cardiovascular events compared to a placebo.*
FDA Label Image

Figure3 (Image 02)

Figure3 (Image 02)
This text contains a list of various statins with their corresponding doses, including Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin at different doses. The text mentions a percent change from baseline in LDL-C levels.*
FDA Label Image

Label Image (Lbl500907974)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.